Drugs Made In America Acquisition (DMII) Accounts Payables (2025)
Drugs Made In America Acquisition (DMII) reported Accounts Payables of $99359.0 for Q4 2025, up 2063.74% quarter-over-quarter from $4592.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Accounts Payables (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Accounts Payables data on file, last reported at $99359.0 in Q4 2025.
- Accounts Payables for Q4 2025 came in at $99359.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $99359.0 (changed N/A YoY), and the FY2025 annual result was $99359.0, changed N/A from the prior year.
- Accounts Payables improved to $99359.0 in Q4 2025 per DMII's latest filing, from $4592.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $99359.0 in Q4 2025 and troughed at $4592.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 167,813.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 144,789.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 50,877.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 56,828.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 39,602.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | 99,359.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,359.00 |
| Sep 30, 2025 | 4,592.00 |